Register Now for NAAF's 39th Annual Patient Conference June 27-30, 2024 in Washington, D.C.!

treatment

FDA Approves LITFULO™ (Ritlecitinib) for Adults and Children ages 12+ with Severe Alopecia Areata

Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for…